MK-8931,
N-(3-(3-amino-5,6-dihydro-2,5-dimethyl-1,1-dioxido-2H-1,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoro-2-pyridinecarboxamide,
SCH-900931,
verubecestat,
Verubecestat,
1286770-55-5,
MK-8931,
UNII-J1I0P6WT7T,
Verubecestat (MK-8931),
Verubecestat Free Base,
J1I0P6WT7T,
N-{3-[(5r)-3-Amino-2,5-Dimethyl-1,1-Dioxido-5,6-Dihydro-2h-1,2,4-Thiadiazin-5-Yl]-4-Fluorophenyl}-5-Fluoropyridine-2-Carboxamide,
Verubecestat [USAN:INN],
example 25 (US8940748),
2-Pyridinecarboxamide, N-(3-((5R)-3-amino-5,6-dihydro-2,5-dimethyl-1,1-dioxido-2H-1,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoro-,
2-Pyridinecarboxamide, N-[3-[(5R)-3-amino-5,6-dihydro-2,5-dimethyl-1,1-dioxido-2H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoro-,
verubecestat-mk-8931,
Verubecestat; MK-8931,
GTPL8699,
Verubecestat (JAN/USAN/INN),
CHEMBL3301601,
SCHEMBL10328722,
SCHEMBL17507398,
BDBM143220,
BCP15722,
EX-A2003,
N-[3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide,
MFCD28963974,
s8564,
AKOS030573301,
ZINC144542146,
CS-5823,
DB12285,
SB19728,
AS-35038,
HY-16759,
J3.514.620B,
A16113,
D10739,
US8940748, 25,
(R)-N-(3-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoropicolinamide,
66F,
N-(3-((5R)-3-amino-2,5-dimethyl-1,1-dioxo-1,2,5,6-tetrahydro-1lambda6,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoropyridine-2-carboxamide,
N-(3-((5R)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H-1lambda6,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoropyridine-2-carboxamide,
D0R4KK,
MK8931,
MK 8931,
1613380-81-6,